# Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients

> **NCT07524829** · NA · RECRUITING · sponsor: **Azienda Sanitaria Locale di Asti** · enrollment: 124 (estimated)

## Conditions studied

- Breast Cancer
- Drug-Related Side Effects and Adverse Reactions
- Chemotherapy Toxicity
- Treatment Adherence
- Treatment-Related Toxicity

## Interventions

- **BEHAVIORAL:** Structured Telenursing Follow-up
- **OTHER:** Standard Nursing Care

## Key facts

- **NCT ID:** NCT07524829
- **Lead sponsor:** Azienda Sanitaria Locale di Asti
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-04-09
- **Primary completion:** 2028-04
- **Final completion:** 2028-09
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07524829

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07524829, "Telenursing for the Early Detection and Management of Side Effects Associated With Cyclin-Dependent Kinase Inhibitors in Breast Cancer Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07524829. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*